FR2683148B1 - Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer. - Google Patents

Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer.

Info

Publication number
FR2683148B1
FR2683148B1 FR929211456A FR9211456A FR2683148B1 FR 2683148 B1 FR2683148 B1 FR 2683148B1 FR 929211456 A FR929211456 A FR 929211456A FR 9211456 A FR9211456 A FR 9211456A FR 2683148 B1 FR2683148 B1 FR 2683148B1
Authority
FR
France
Prior art keywords
preparing
same
pharmaceutical products
tumor diseases
curing tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR929211456A
Other languages
English (en)
Other versions
FR2683148A1 (fr
Inventor
Gabor Somlyai
Somlyai Gabor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D H ALAPITVANY EGESZSEGES
Original Assignee
D H ALAPITVANY EGESZSEGES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D H ALAPITVANY EGESZSEGES filed Critical D H ALAPITVANY EGESZSEGES
Publication of FR2683148A1 publication Critical patent/FR2683148A1/fr
Application granted granted Critical
Publication of FR2683148B1 publication Critical patent/FR2683148B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR929211456A 1991-10-31 1992-09-25 Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer. Expired - Lifetime FR2683148B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases

Publications (2)

Publication Number Publication Date
FR2683148A1 FR2683148A1 (fr) 1993-05-07
FR2683148B1 true FR2683148B1 (fr) 1994-09-09

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
FR929211456A Expired - Lifetime FR2683148B1 (fr) 1991-10-31 1992-09-25 Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer.

Country Status (22)

Country Link
US (1) US5855921A (fr)
JP (1) JP3569916B2 (fr)
KR (1) KR100253874B1 (fr)
CN (1) CN1045162C (fr)
AT (1) AT402692B (fr)
BE (1) BE1006186A3 (fr)
CA (1) CA2122612C (fr)
CH (1) CH685282A5 (fr)
CZ (1) CZ282379B6 (fr)
DE (1) DE4232465B4 (fr)
DK (1) DK170832B1 (fr)
ES (1) ES2077530B1 (fr)
FI (1) FI114010B (fr)
FR (1) FR2683148B1 (fr)
GB (1) GB2276086B (fr)
HU (1) HU208084B (fr)
IT (1) IT1255390B (fr)
LU (1) LU88175A1 (fr)
NL (1) NL194664C (fr)
NO (1) NO307031B1 (fr)
SE (1) SE513624C2 (fr)
WO (1) WO1993008794A1 (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09511129A (ja) * 1994-01-06 1997-11-11 ハーイデー クタトー−フェイレステー カーエフテー 病気予防のための食品及びその製造方法
HU214824B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Bőrbetegségek kezelésére és megelőzésére alkalmas kozmetikai, higiéniai, valamint szépség- és testápolási készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
EP1483399B1 (fr) * 2002-02-12 2008-10-29 The Regents of the University of California Mesure de vitesses de biosynthese et de degradation de molecules biologiques inaccessibles ou peu accessibles a un echantillonnage direct, de maniere non invasive, par incorporation d'etiquettes dans des derives metaboliques et des produits cataboliques
JP4804753B2 (ja) 2002-07-30 2011-11-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 質量分析法を使用した、プロテオームまたはオルガネオームの分子フラックス速度の自動化大規模測定
AU2002321678A1 (en) * 2002-09-09 2004-03-29 Boros Béla Oxygen-enriched water, treated within a magnetic field and heavy water
EP1546373B1 (fr) * 2002-09-13 2008-11-26 The Regents of the University of California Methodes permettant de mesurer les taux de transport inverse du cholesterol in vivo utilises comme indice d'anti-atherogenicite
AU2003291731B2 (en) 2002-11-04 2009-09-10 The Regents Of The University Of California Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水（スーパーライトウォーター）を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (fr) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Composition pharmaceutique comprenant de l'eau appauvrie en isotopes lourds o17 et o8
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (fr) * 2004-06-03 2005-12-15 Kunihiro Seki Appareil de production d’un aliment a faible concentration de deuterium
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
ATE505532T1 (de) * 2005-02-08 2011-04-15 Woodford Associates Ltd Mit 1h2160 angereichertes alkoholisches getränk
CA2597096C (fr) * 2005-02-08 2013-05-21 Woodford Associates Limited Boisson sans alcool enrichie de 1h216o
JP4598832B2 (ja) * 2005-03-05 2010-12-15 パブロヴィッチ ソロヴィエフ，セルゲイ １ｈ２１６ｏが濃縮された化粧品組成物
US20080103092A1 (en) * 2005-03-11 2008-05-01 Pomytkin Igor A Methods for Intradermal, Transdermal or Transmucosal Delivery of Biologically Active Substances
US20080160102A1 (en) * 2005-03-11 2008-07-03 Igor Anatolievich Pomytkin Compositions For Disfecing Inanimate Surfaces
WO2006098650A1 (fr) * 2005-03-11 2006-09-21 Vada Consulting Limited Eau pharmaceutique legere, compositions therapeutiques et procedes correspondants
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
WO2007069932A1 (fr) * 2005-12-12 2007-06-21 Vada Consulting Limited Procede pour supprimer l'appetit et l'ingestion d'aliments
EA014536B1 (ru) * 2005-12-12 2010-12-30 Тимантти Аб Способ лечения метаболического синдрома
WO2007069933A1 (fr) * 2005-12-12 2007-06-21 Vada Consulting Limited Procede pour reduire la glycemie postprandiale
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE102009017966A1 (de) 2009-04-21 2010-11-04 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
US20130129671A1 (en) * 2011-05-27 2013-05-23 Bristol-Myers Squibb Company Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus
HUP1100290A2 (en) 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
JP2014526685A (ja) 2011-09-08 2014-10-06 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 代謝流量測定、画像化、および顕微鏡法
EP3435088A1 (fr) 2011-12-07 2019-01-30 GlaxoSmithKline LLC Procédés de détermination de la masse musculaire squelettique corporelle totale
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
WO2014088441A1 (fr) * 2012-12-03 2014-06-12 Igor Anatolievich Pomytkin Aliment pour la gestion diététique du syndrome d'épuisement professionnel
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
EP3160590B1 (fr) * 2014-06-30 2018-04-25 Mitochondrial Substrate Invention Limited Solutions de substances nutritives pour l'amélioration de la fonction cognitive
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
CN109843407A (zh) 2016-09-21 2019-06-04 安布罗休斯·坎波利斯 同位素组合物
CA3087342A1 (fr) 2018-01-02 2019-07-11 Botanical Water Technologies Ip Ltd Eau enrichie d'isotopes
WO2019174659A1 (fr) 2018-03-15 2019-09-19 Karl Bau Gmbh Procédé et ensemble servant à fabriquer de l'eau à teneur réduite en deutérium
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
US4874780A (en) * 1987-03-11 1989-10-17 Norsk Hydro A.S. Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
WO1989001342A2 (fr) * 1987-08-07 1989-02-23 Mallinckrodt, Inc. Composition diagnostique ou radiotherapeutique comprenant un compose a base d'hydrogene
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Also Published As

Publication number Publication date
NL9220026A (nl) 1994-09-01
SE9401406L (sv) 1994-06-07
CH685282A5 (de) 1995-05-31
JP3569916B2 (ja) 2004-09-29
AT402692B (de) 1997-07-25
CA2122612A1 (fr) 1993-05-13
DE4232465A1 (de) 1993-05-06
CA2122612C (fr) 2003-02-04
ES2077530A1 (es) 1995-11-16
FI941979A (fi) 1994-06-29
SE9401406D0 (sv) 1994-04-25
NO307031B1 (no) 2000-01-31
ITMI922233A0 (it) 1992-09-28
NL194664B (nl) 2002-07-01
FI114010B (fi) 2004-07-30
CN1045162C (zh) 1999-09-22
BE1006186A3 (fr) 1994-06-07
ITMI922233A1 (it) 1994-03-28
KR930007461A (ko) 1993-05-20
FI941979A0 (fi) 1994-04-29
ES2077530B1 (es) 1996-07-01
WO1993008794A1 (fr) 1993-05-13
GB9408654D0 (en) 1994-07-20
CZ102094A3 (en) 1994-12-15
NL194664C (nl) 2002-11-04
HU208084B (en) 1993-08-30
CN1071836A (zh) 1993-05-12
CZ282379B6 (cs) 1997-07-16
US5855921A (en) 1999-01-05
KR100253874B1 (ko) 2000-04-15
DK170832B1 (da) 1996-02-05
FR2683148A1 (fr) 1993-05-07
GB2276086A (en) 1994-09-21
GB2276086B (en) 1995-09-27
IT1255390B (it) 1995-10-31
NO941590D0 (fr) 1994-04-29
HU913437D0 (en) 1992-01-28
NO941590L (fr) 1994-06-23
SE513624C2 (sv) 2000-10-09
LU88175A1 (fr) 1993-03-15
ATA902992A (de) 1996-12-15
JPH08501275A (ja) 1996-02-13
DE4232465B4 (de) 2008-11-06

Similar Documents

Publication Publication Date Title
FR2683148B1 (fr) Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer.
MA22493A1 (fr) Conditionnement pour produits agrochimiques et procede pour sa production
GB2247837B (en) Pharmaceutical product for the treatment of immunoregulatory disorders
ITRM920782A0 (it) Procedimento per la produzione di manufatti in acciaio inossidabile super-duplex.
MA26410A1 (fr) Formulations pharmaceutiques et procede pour leur production.
FR2649888B1 (fr) Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
FR2557772B1 (fr) Procede de preparation de produits alimentaires granulaires a fluidite et a solubilite ameliorees.
US5093080B1 (en) Conservation process for agricultural products
FR2628324B1 (fr) Compositions pharmaceutiques antivirales et immunostimulantes et procede pour les preparer
GR3014958T3 (en) 2,4- and 2,5-Pyridine-dicarboxylic-acid derivatives, process for their preparation, their use and medicines based on these compounds.
DE2962631D1 (en) Process for the sterilization of pharmaceutical products
FR2584727B1 (fr) Procede d'extraction de proteines du lait, produits, application du procede, et compositions pharmaceutiques
MA23518A1 (fr) Procede de preparation de produits pharmaceutiques
FR2629471B1 (fr) Procede de preparation de demi-produits en cuir
ES265002Y (es) "soporte para producto higienico".
DK0596948T3 (da) Osteprodukt og fremgangsmåde til dets fremstilling
ZA88754B (en) Substituted 3,4-dihydro-2h-benzopyrans,processes for their preparation,their use and pharmaceutical products based on these compounds
ZA89121B (en) New 3,5-dihydroxy carboxylic acids and derivatives thereof,a process for the preparation thereof,the use thereof as pharmaceuticals,pharmaceutical products and intermediates
DK523388D0 (da) Magnesiumadditiv til naerings-, foder- og laegemidler
MA22880A1 (fr) Procede de preparation de produits pharmaceutiques .
FR2652566B1 (fr) Perfectionnement aux emballages pour le conditionnement de produits notamment alimentaires.
HUT47295A (en) Process for producing 2-(methoxymethyl)-penem derivatives and pharmaceuticals comprising same
FR2655340B1 (fr) Procede de preparation de produits intermediaires pour la preparation de diltiazem.
FR2614183B1 (fr) Composition d'addition pour produits d'alimentation humaine.
FR2604356B1 (fr) Compositions pharmaceutiques transdermiques multicouches ayant un effet prolonge et procede pour les preparer